GlassScriptPhysician profile
Ginny Ann Walton
NPI 1447919642
$5,278.06
in general payments reported to CMS, 2019-2025
42 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,341 · 2023: $1,992 · 2024: $1,550 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,937.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $652.82 | 2022-2025 | Briviact, Fintepla, Nayzilam |
| Sk Life Science, INC. | $396.90 | 2022-2024 | Xcopri |
| Abbvie INC. | $375.38 | 2022-2024 | |
| Biogen, INC. | $296.10 | 2022-2025 | Vumerity, Leqembi, Plegridy |
| Alexion Pharmaceuticals, INC. | $278.32 | 2022-2025 | Ultomiris |
| Lundbeck LLC | $255.25 | 2022-2024 | Vyepti, Rexulti |
| Lilly USA, LLC | $221.59 | 2022-2025 | Amyvid, Emgality, Kisunla |
| Emd Serono, INC. | $212.30 | 2022-2023 | Mavenclad |
| Pfizer INC. | $206.57 | 2023-2024 | |
| Neurelis, INC. | $194.47 | 2022-2024 | Valtoco |
| Eisai INC. | $187.05 | 2022-2024 | |
| Livanova USA, INC. | $177.86 | 2023-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceutical Holding Company LTD. | $164.50 | 2022 | |
| Ani Pharmaceuticals, INC. | $151.76 | 2022-2023 | Purified Cortrophin Gel |
| Teva Pharmaceuticals USA, INC. | $150.00 | 2022-2023 | Austedo |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $116.69 | 2022-2023 | Vyvgart |
| Boston Scientific Corporation | $109.33 | 2024-2025 | Watchman Flx |
| Tg Therapeutics, INC. | $105.45 | 2023-2024 | |
| Acorda Therapeutics, INC | $94.69 | 2022-2023 | Inbrija, Ampyra |
| Jazz Pharmaceuticals INC. | $74.93 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $74.07 | 2022-2023 | |
| Genentech USA, INC. | $72.19 | 2023-2024 | Ocrevus Zunovo, Enspryng, Ocrevus |
| Grifols USA, LLC | $71.32 | 2022-2023 | Gamunex-C |
| Janssen Pharmaceuticals, INC | $70.57 | 2022 | |
| Insightec,INC | $70.34 | 2023 | Exablate |
| Avion Pharmaceuticals | $59.65 | 2022 | |
| Csl Behring | $56.11 | 2022-2024 | Hizentra |
| Celgene Corporation | $53.73 | 2023 | Zeposia |
| Sumitomo Pharma America, INC. | $50.92 | 2023 | Aptiom |
| Genzyme Corporation | $36.28 | 2023 | |
| Kyowa Kirin, INC. | $35.82 | 2023 | Nourianz |
| Novocure INC. | $25.96 | 2024 | Optune |
| Microtransponder, INC. | $24.06 | 2025 | |
| Sunovion Pharmaceuticals INC. | $23.07 | 2022 | |
| Tersera Therapeutics LLC | $22.33 | 2024 | Quzyttir |
| Takeda Pharmaceuticals U.S.A., INC. | $21.07 | 2024 | Hyqvia |
| Tms Neurohealth Centers INC. | $19.82 | 2025 | Tms Neurohealth Centers INC. |
| Collegium Pharmaceutical, INC. | $14.86 | 2022 | |
| Corium, LLC | $14.00 | 2023 | Adlarity |
| Janssen Biotech, INC. | $13.63 | 2025 | |
| Merck Sharp & Dohme LLC | $13.44 | 2022 | |
| Impel Pharmaceuticals INC. | $12.86 | 2023 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginny Walton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.